Treco Douglas A

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

-4.7%

median move per position

+9.9%

S&P 500 median, same spans

0 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$1.14M bought

All filings on record

Every Form 4 transaction we track for this filer

All3Buys1Sells0

Stock	Transaction	Date	~6mo vs S&P
CRSPCRISPR Therapeutics AG	Buy $1.14M · 20,000 sh	2025-08-06	—
INZYInozyme Pharma, Inc.	Other $175.4K · 43,861 sh	2025-07-01	—
INZYInozyme Pharma, Inc.	Grant $2.1K · 2,815 sh	2025-06-25	—

CRSPBuy

2025-08-06 · CRISPR Therapeutics AG

$1.14M

—

INZYOther

2025-07-01 · Inozyme Pharma, Inc.

$175.4K

—

INZYGrant

2025-06-25 · Inozyme Pharma, Inc.

$2.1K

—

3 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

PR

Prasad Raju

CRSP · last 2026-08-07

PN

Patel Naimish

CRSP · last 2026-05-29

KJ

Kasinger James R.

CRSP · last 2026-02-19

KS

Kulkarni Samarth

CRSP · last 2026-02-19

GS

George Simeon

CRSP · last 2025-07-16

BA

Bolte Axel

INZY · last 2025-07-01

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.